Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
about
c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-cateninLithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta.Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing.Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma.Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patientsSulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancerROS1 gene rearrangement and copy number gain in non-small cell lung cancer.Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells.Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC; a central role of TP53 mutations.
P2860
Q35795297-7962D486-695F-450F-A209-58706D86A41DQ36130607-090BB3C6-DE52-4C8F-8E08-6969D12C6A9FQ36189756-46EEB57D-8521-4735-A5E6-E1FCCDB7C9EEQ36545951-6BBB1E35-0F7D-4FA9-8B35-79058F9A8B2FQ37133253-EBA2B0EB-D16B-4E2F-81D0-A043BF5E14BEQ37374550-AB82A772-C8B9-4790-BF33-6DBF8C579DEEQ37680199-C22FC2AD-040E-4E3F-B8D4-925DBCEA49A0Q37707047-3B68D79E-5FA7-49AB-8F84-11FB42CE7B5AQ39102554-6F2BB28A-E49B-420F-ABDA-4D6CBC0A2ED2Q39369140-F6F66AF6-F37B-4D34-8E7F-75C9332182E7Q41233667-DEB189BF-48FE-461E-AC44-8CDF26D253E2Q42024762-6BDA8412-7DD2-4F5C-8F5B-CBD9ABEDB886Q42378381-412113F2-A224-45C9-8815-1EFC702432FBQ46758501-8F0A8966-B7A2-48AB-9511-08CE800362FAQ47093822-28F36B7D-5BC5-41D6-9D32-ADF5F5DF0C4AQ47166342-C1C9CB29-1C55-42A1-A7FC-EB2C937E01E9Q52366358-1B924D7F-E519-4159-9A91-5F1DB7A5CB44Q52370966-FEBF35F1-9884-46FF-AA48-792369A0093CQ53644101-FE70FD09-0030-4A76-BDFC-EEE94D9255FAQ54976636-BF151112-AEB6-4019-8014-A940E7765397
P2860
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Clinicopathologic and prognost ...... gain in lung adenocarcinomas.
@en
type
label
Clinicopathologic and prognost ...... gain in lung adenocarcinomas.
@en
prefLabel
Clinicopathologic and prognost ...... gain in lung adenocarcinomas.
@en
P2093
P2860
P356
P1476
Clinicopathologic and prognost ...... gain in lung adenocarcinomas.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.218
P407
P577
2014-05-08T00:00:00Z
P5875
P6179
1016777244